Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cadence Pharmaceuticals Inc CADX

Healthcare Biotechnology

Recent & Breaking News (NDAQ:CADX)

Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.

Business Wire March 19, 2014

Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results

PR Newswire February 28, 2014

Lifshitz & Miller Law Firm Announces Investigation of Cadence Pharmaceuticals, Inc., Chindex International, Inc., LCA-Vision, Inc., North Valley Bancorp and Texas Industries, Inc.

PR Newswire February 19, 2014

SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. in Connection With the Sale of the Company to Mallinckrodt plc

Business Wire February 17, 2014

CADENCE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

PR Newswire February 14, 2014

SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc.

Business Wire February 14, 2014

INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. and Its Board of Directors in Connection with the Sale of the Company to Mallinckrodt plc -- CADX

Business Wire February 13, 2014

CADENCE INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating Cadence Pharmaceuticals, Inc. (CADX) in Relation to the Proposed Sale of the Company to Mallinckrodt plc

Business Wire February 13, 2014

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. - CADX

PR Newswire February 12, 2014

Cadence Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Mallinckrodt plc

Business Wire February 12, 2014

Ryan & Maniskas, LLP Announces Investigation of Cadence Pharmaceuticals Inc.

PR Newswire February 12, 2014

TrendingWallStreet.com Begins Volume Analysis on MODN, CADX, BIEL, and MEDL

Accesswire February 12, 2014

Harwood Feffer LLP Announces Investigation of Cadence Pharmaceuticals, Inc.

PR Newswire February 11, 2014

Cadence Pharmaceuticals (CADX) to be acquired by Mallinckrodt for $1.3b: Lawsuit talk begins within hours

Chris Parry February 11, 2014

Acquisition of Cadence Pharmaceuticals, Inc. by Mallinckrodt plc May Not Be in Shareholders' Best Interests

PR Newswire February 11, 2014

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cadence Pharmaceuticals, Inc. Stockholders

Business Wire February 11, 2014

SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Cadence Pharmaceuticals, Inc. - CADX

PR Newswire February 11, 2014

CADENCE SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cadence Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Mallinckrodt plc in a Cash Deal

PR Newswire February 11, 2014

INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. and Its Board of Directors In Connection With the Sale of the Company to Mallinckrodt plc -- CADX

Business Wire February 11, 2014

CADENCE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

Business Wire February 11, 2014